Design Therapeutics (DSGN) EPS (Basic) (2020 - 2026)
Design Therapeutics' (DSGN) quarterly EPS (Basic) came in at -$0.29 in Q1 2026, up 6.45% year-on-year from -$0.27 in Q1 2025, and down 7.41% quarter-over-quarter from -$0.27 in Q4 2025.
Design Therapeutics (DSGN) EPS (Basic) (2020 - 2026) Analysis & Trends
Design Therapeutics has disclosed EPS (Basic) across 7 years of filings, most recently posting -$0.29 for Q1 2026.
- EPS (Basic) for Q1 2026 came in at -$0.29, up 6.45% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.2 (down 21.21% YoY), and the FY2025 annual result was -$1.22, down 38.64% from the prior year.
- EPS (Basic) came in at -$0.29 for Q1 2026 at Design Therapeutics, down from -$0.27 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.2 in Q1 2024 to a low of -$0.36 in Q2 2023.
- The 5-year median for EPS (Basic) is -$0.28 (2023), against an average of -$0.28.
- Across the five-year window, EPS (Basic) tumbled 92.86% in 2022 and soared 42.86% in 2024, its largest moves.
- Design Therapeutics' EPS (Basic) stood at -$0.31 in 2022, then soared by 32.26% to -$0.21 in 2023, then fell by 14.29% to -$0.24 in 2024, then declined by 12.5% to -$0.27 in 2025, then retreated by 7.41% to -$0.29 in 2026.
- The last three EPS (Basic) figures came in at -$0.29 (Q1 2026), -$0.27 (Q4 2025), and -$0.3 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 0.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.06 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.06 |
| 10 | Design Therapeutics | 763.94 Mn | 541.11 Mn | - | -0.29 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.29 |
| Dec 31, 2025 | -0.27 |
| Sep 30, 2025 | -0.30 |
| Jun 30, 2025 | -0.34 |
| Mar 31, 2025 | -0.31 |
| Dec 31, 2024 | -0.24 |
| Sep 30, 2024 | -0.23 |
| Jun 30, 2024 | -0.21 |
| Mar 31, 2024 | -0.20 |
| Dec 31, 2023 | -0.21 |
| Sep 30, 2023 | -0.28 |
| Jun 30, 2023 | -0.36 |
| Mar 31, 2023 | -0.35 |
| Dec 31, 2022 | -0.31 |
| Sep 30, 2022 | -0.32 |
| Jun 30, 2022 | -0.27 |
| Mar 31, 2022 | -0.24 |
| Dec 31, 2021 | -0.20 |
| Sep 30, 2021 | -0.21 |
| Jun 30, 2021 | -0.14 |